Skip to main content

MoneyWorks4Me

Sandu Pharmaceuticals informs about disclosure

18 Jul 2022 Evaluate

Sandu Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanbro Marketing Services.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..